版本:
中国

BRIEF-Rigel Pharmaceuticals enters into amendment to controlled equity offerings sales agreement

May 30 Rigel Pharmaceuticals Inc

* Entered into amendment no. 1 to controlled equity offerings sales agreement, dated august 18, 2015 - SEC filing

* Co may offer and sell through Cantor additional shares of co's common stock, having aggregate offering price of up to $40.0 million Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐